- Home
- Products
- Customized ADCs
- TNFRSF8
- Anti-TNFRSF8-DIBO-doxorubicin ADC-12
Anti-TNFRSF8-DIBO-doxorubicin ADC-12 (CAT#: ADC-W-340)
This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cAC10) conjugated via a DIBO linker to a doxorubicin. The doxorubicin is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, doxorubicin binds to DNA, causes DNA damage.
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Name
- TNFRSF8
- Alternative Names
- TNFRSF8; tumor necrosis factor receptor superfamily, member 8; CD30; Ki-1; D1S166E; tumor necrosis factor receptor superfamily member 8; Ki-1 antigen; CD30L receptor; cytokine receptor CD30; lymphocyte activation antigen CD30;
- Target Entrez Gene ID
- 943
- Target UniProt ID
- A5D8T4
- Overview
- The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed by activated, but not by resting, T and B cells. TRAF2 and TRAF5 can interact with this receptor, and mediate the signal transduction that leads to the activation of NF-kappaB. This receptor is a positive regulator of apoptosis, and also has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported.
- Overview
- Chimeric Anti-TNFRSF8 Antibody, cAC10
- Generic name
- cAC10
- Species Reactivity
- Human
- Name
- DIBO (dibenzylcyclooctynol)
- Name
- doxorubicin
- Description
- Doxorubicin is a type of anti-cancer chemotherapy drug called an anthracycline. Doxorubicin works by blocking an enzyme called TopoisomeraseⅡthat cancer cells need to divide and grow.
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-340. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Linker
Same Payload
| CAT# | Product Name | Linker | Payload |
| ADC-W-465 | Anti-TNFRSF8 (Brentuximab)-VC-PAB-MMAE ADC | VC-PAB (valine-citrulline with PAB) | MMAE (Monomethyl auristatin E) |
| ADC-W-356 | Anti-CD30 receptorc-Mc-VC-PABC-MMAF ADC-12 | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-2346 | Anti-TNFRSF8 (Brentuximab )-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-1889 | Anti-TNFRSF8 (Iratumumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-2343 | Anti-TNFRSF8 (Brentuximab )-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| CAT# | Product Name | Linker | Payload |
| ADC-W-339 | Anti-CD22-DIBO-doxorubicin ADC | DIBO (dibenzylcyclooctynol) | doxorubicin |
| CAT# | Product Name | Linker | Payload |
| ADC-W-503 | Anti-EGFR-EDC/NHS-Dox ADC | EDC/NHS(1-ethyl-3-(3-diaminopropyl)carbodiimide/N-hydroxysuccinimide) | Doxorubicin |
| ADC-W-578 | Anti-CD74-MCC-Dox ADC | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | doxorubicin |
| ADC-W-504 | Anti-EGFR (cetuximab)-SMCC-Doxorubicin ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | Doxorubicin |
| ADC-W-479 | Anti-CD74-SMCC-Dox ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | Doxorubicin |
| ADC-W-463 | Anti-FUT3-Mc-Dox ADC | Mc (maleimidocaproyl) | Doxorubicin |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-MUC1 (Sontuzumab)-SMCC-DM1 ADC (CAT#: ADC-W-2486)
- Anti-MS4A1-SPP-DM1 ADC (CAT#: ADC-W-617)
- Anti-HCMV (Regavirumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-2105)
- Anti-CD2 (Siplizumab)-MC-MMAF ADC (CAT#: ADC-W-784)
- Anti-MS4A1-Mc-VC-PABC-MMAE ADC (CAT#: ADC-W-619)
- Anti-DLL3-PBD dimers ADC-2 (CAT#: ADC-W-104)
- Anti-CD22-Mc-MMAF ADC-9 (CAT#: ADC-W-217)
- Anti-ITGA4+ITGB7 (Abrilumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-2388)
- Anti-DLL3-PBD dimers ADC-3 (CAT#: ADC-W-105)
- Anti-CEACAM6 (Sulesomab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-979)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
